Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1373302 | Bioorganic & Medicinal Chemistry Letters | 2009 | 6 Pages |
Abstract
A novel class of imidazopyridine derivatives was designed as PLK1 inhibitors. Extensive SAR studies supported by molecular modeling afforded a highly potent and selective compound 36. Compound 36 demonstrated good antitumor efficacy in xenograft nude rat model.
Graphical abstractDesign and optimization of novel imidazopyridine derivatives led to the identification of a potent and selective PLK inhibitor 36.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Yoshiyuki Sato, Yu Onozaki, Tetsuya Sugimoto, Hideki Kurihara, Kaori Kamijo, Chie Kadowaki, Toshiaki Tsujino, Akiko Watanabe, Sachie Otsuki, Morihiro Mitsuya, Masato Iida, Kyosuke Haze, Takumitsu Machida, Yoko Nakatsuru, Hideya Komatani, Hidehito Kotani,